The higher contribution of BHG among T1D also explains why the emerging advanced closed‐loop automated insulin delivery system, which was currently able to adjust the basal glycemia automatedly, could have outstanding effects in glycemic control with approximately 75%–85% glucose levels maintained in target even though the precise and evidence‐sufficient strategies of postmeal glycemic control have not been fully developed.20 The gene discussed is INS; the disease is type 1 diabetes mellitus.